Total buying$2.97k1 buys
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
NYSEConsumer DiscretionaryServices-Commercial Physical & Biological Research
Insider activity for last month from 09/19 to 10/19.
How these metrics are calculated
Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total selling$302k1 sells
Net open-market−$299kBuying minus selling
Active insiders2Distinct reporting owners
Insider activity report
Calendar-month buckets within the selected date range
Latest filing: Oct 08, 2026
Open-market transaction mix · 2 transactions in the selected period
Code A includes awards, grants and other acquisitions; these are not open-market buys. A rolling period can include partial calendar months.
View exact monthly counts and disclosed values
| Month | Buys | Sells | Awards (A) | Buy value | Sell value | Net P/S value |
|---|---|---|---|---|---|---|
| Sep 2026 | 1 | 0 | 0 | $2.97k | $0 | $2.97k |
| Oct 2026 | 0 | 1 | 0 | $0 | $302k | -$302k |
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (1)Sep 2026Oct 2026
Largest insider activity
By absolute net disclosed value · current transaction page- PM-$98.1k
- CG+$3.0k
CRL transaction history
Newest filings · 20 transactions per pageLatest insider transactions
Form 4 filings from last month.| Company | Insider | Activity | Disclosed value | Filed (ET) |
|---|---|---|---|---|
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Parisotto Shannon MCEVP · DISC · SA | M · exercise10b5-1 detectedDerivative securitySEC filing ↗ | $0View disclosure → | |
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Parisotto Shannon MCEVP · DISC · SA | S · sale10b5-1 detectedSEC filing ↗ | -$302kView disclosure → | |
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Parisotto Shannon MCEVP · DISC · SA | M · exercise10b5-1 detectedSEC filing ↗ | $204kView disclosure → | |
CRLCHARLES RIVER LABORATORIES INTERNATIONAL, INC. | Coleman GlennEVP · CFO | P · buySEC filing ↗ | $2.97kView disclosure → |
Filing-only signals
Deterministic matches in the selected period
Recent filing activity
Most recent 4 transactions on this page · color = transaction codeFiling detail checks
Secondary metrics for the selected periodTransaction codes
By Form 4 transaction code in selected period4transactionstxns
- M · Option exercise · dominant2 · 50%
- P · Open-market buys1 · 25%
- S · Open-market sells1 · 25%
Activity by reported role
A joint filing can contribute to multiple rolesCEVP3
DISC3
SA3
Chief financial officer1
EVP1
Reported Holdings After
Separated by insider, security, and ownership type
Parisotto Shannon MCommon Stock · Direct
4,807Oct 05, 2026
Coleman GlennCommon Stock · Direct
27,762Sep 30, 2026
Parisotto Shannon MStock Options (Right to Buy) · Direct
2,944Oct 05, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Current transaction page only · each cell is a filing date · buys green, sells redSep 19 → Oct 19
LessMore
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at CHARLES RIVER LABORATORIES INTERNATIONAL, INC.?
Parisotto Shannon M, Coleman Glenn.
When was the latest reported open-market purchase?
Coleman Glenn reported a buy on Sep 30, 2026 valued at $2.97k. Read the SEC filing.
When was the latest reported open-market sale?
Parisotto Shannon M reported a sale on Oct 05, 2026 valued at $302k. Read the SEC filing.
What is the recent purchase and sale balance?
Net open-market selling in the selected period was $299,605.34. Sales can occur for many non-investment reasons.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.